T1	PROC 46 60	ENSAYO CLÍNICO
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	DISO 78 100	MASTOCITOSIS SISTÉMICA
#2	AnnotatorNotes T2	C0221013; Mastocytosis, Systemic; Neoplastic Process
T3	DISO 209 217	MUTACIÓN
T4	CHEM 126 144	ANÁLOGO DE PURINAS
#3	AnnotatorNotes T4	C1268902; Purine analog; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T5	CHEM 157 162	2-CDA
T6	CHEM 145 155	CLADRIBINA
#4	AnnotatorNotes T6	C0092801; cladribine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T7	CHEM 166 193	INTERFERÓN ALFA-2A PEGILADO
T8	DISO 240 250	MUTACIONES
#5	AnnotatorNotes T8	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T9	PROC 297 311	ENSAYO CLÍNICO
#6	AnnotatorNotes T9	C0008976; Clinical Trials; Research Activity
T10	DISO 329 351	MASTOCITOSIS SISTÉMICA
#7	AnnotatorNotes T10	C0221013; Mastocytosis, Systemic; Neoplastic Process
T11	DISO 460 468	MUTACIÓN
T12	CHEM 377 395	ANÁLOGO DE PURINAS
#8	AnnotatorNotes T12	C1268902; Purine analog; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T13	CHEM 408 413	2-CDA
T14	CHEM 396 406	CLADRIBINA
#9	AnnotatorNotes T14	C0092801; cladribine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T15	CHEM 417 444	INTERFERÓN ALFA-2A PEGILADO
T16	DISO 491 501	MUTACIONES
#10	AnnotatorNotes T16	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T17	DISO 548 570	Mastocitosis sistémica
#11	AnnotatorNotes T17	C0221013; Mastocytosis, Systemic; Neoplastic Process
T18	DISO 596 604	mutación
T19	DISO 619 629	mutaciones
#12	AnnotatorNotes T19	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T20	PROC 708 719	Diagnóstico
#13	AnnotatorNotes T20	C0011900; Diagnosis; Diagnostic Procedure
T21	DISO 723 745	mastocitosis sistémica
#14	AnnotatorNotes T21	C0221013; Mastocytosis, Systemic; Neoplastic Process
T22	DISO 821 829	mutación
T23	DISO 949 982	Alteración de la función hepática
T24	ANAT 974 982	hepática
#15	AnnotatorNotes T24	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T25	PROC 984 1001	bilirrubina total
#16	AnnotatorNotes T25	C0201913; Bilirubin, total measurement; Laboratory Procedure
T26	PROC 897 921	consentimiento informado
#17	AnnotatorNotes T26	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T27	PROC 1021 1024	GPT
#18	AnnotatorNotes T27	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T28	DISO 1093 1105	mastocitosis
#19	AnnotatorNotes T28	C0024899; Mastocytosis; Disease or Syndrome
T29	DISO 1107 1137	Alteración de la función renal
T30	DISO 844 854	mutaciones
#20	AnnotatorNotes T30	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T31	DISO 1185 1197	mastocitosis
#21	AnnotatorNotes T31	C0024899; Mastocytosis; Disease or Syndrome
T32	DISO 1199 1209	Citopenias
#22	AnnotatorNotes T32	C0010828; Cytopenia; Pathologic Function
T33	DISO 1246 1258	mastocitosis
#23	AnnotatorNotes T33	C0024899; Mastocytosis; Disease or Syndrome
T34	DISO 1260 1271	Cardiopatía
#24	AnnotatorNotes T34	C0018799; Heart Diseases; Disease or Syndrome
T35	PROC 1306 1351	fracción de eyección del ventrículo izquierdo
#25	AnnotatorNotes T35	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T36	ANAT 1331 1351	ventrículo izquierdo
#26	AnnotatorNotes T36	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T37	PROC 1417 1440	métodos anticonceptivos
#27	AnnotatorNotes T37	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T38	DISO 765 796	mastocitosis sistémica agresiva
#28	AnnotatorNotes T38	C1112486; Aggressive Systemic Mastocytosis; Neoplastic Process
T39	CHEM 984 995	bilirrubina
#29	AnnotatorNotes T39	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T40	PROC 1015 1018	GOT
#30	AnnotatorNotes T40	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T41	ANAT 1132 1137	renal
#31	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	PROC 1139 1149	creatinina
#32	AnnotatorNotes T42	C0201975; Creatinine measurement; Laboratory Procedure
T43	Date 13 17	2012
T44	LIVB 64 73	PACIENTES
#33	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 197 204	SUJETOS
#34	AnnotatorNotes T45	C0681850; Study Subject; Group
T46	LIVB 315 324	PACIENTES
#35	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 448 455	SUJETOS
#36	AnnotatorNotes T47	C0681850; Study Subject; Group
T48	Age 683 706	igual o mayor a 18 años
T55	PROC 1299 1303	NYHA
#37	AnnotatorNotes T55	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T56	PHYS 1360 1368	Embarazo
#38	AnnotatorNotes T56	C0032961; Pregnancy; Organism Function
T57	PHYS 1371 1380	lactancia
#39	AnnotatorNotes T57	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T58	LIVB 1382 1404	Mujeres en edad fértil
#40	AnnotatorNotes T58	C4324275; Woman of childbearing potential; Population Group
T59	Age 1393 1404	edad fértil
T61	Neg_cue 1409 1411	no
T62	PHYS 1318 1351	eyección del ventrículo izquierdo
#41	AnnotatorNotes T62	C2733342; Left ventricular ejection; Physiologic Function
T63	GENE 257 272	EXÓN 17 DEL KIT
#42	AnnotatorNotes T63	C4533734; KIT gene exon 17; Gene or Genome
T64	GENE 508 523	EXÓN 17 DEL KIT
#43	AnnotatorNotes T64	C4533734; KIT gene exon 17; Gene or Genome
T65	GENE 636 650	exón 17 de KIT
#44	AnnotatorNotes T65	C4533734; KIT gene exon 17; Gene or Genome
T66	GENE 861 875	exón 17 de KIT
#45	AnnotatorNotes T66	C4533734; KIT gene exon 17; Gene or Genome
T49	PHYS 966 982	función hepática
#46	AnnotatorNotes T49	C0232741; Liver function; Organ or Tissue Function
T50	PHYS 1124 1137	función renal
#47	AnnotatorNotes T50	C0232804; Renal function; Organ or Tissue Function
A1	Population_data T58 Age
A2	Assertion T37 Negated
#48	AnnotatorNotes T18	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#49	AnnotatorNotes T22	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#50	AnnotatorNotes T11	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#51	AnnotatorNotes T3	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#52	AnnotatorNotes T5	C0092801; cladribine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
#53	AnnotatorNotes T13	C0092801; cladribine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T51	Neg_cue 1223 1225	no
T52	Neg_cue 1163 1165	no
T53	Quantifier_or_Qualifier 1226 1238	relacionadas
A3	Assertion T53 Negated
T54	Quantifier_or_Qualifier 1166 1177	relacionada
A4	Assertion T54 Negated
T60	Quantifier_or_Qualifier 1074 1085	relacionada
A5	Assertion T60 Negated
T67	Neg_cue 1071 1073	no
T68	Observation 574 588	mal pronóstico
#54	AnnotatorNotes T68	C0278252; Prognosis bad; Finding
T69	Observation 749 763	mal pronóstico
#55	AnnotatorNotes T69	C0278252; Prognosis bad; Finding
R1	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T68	
R2	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T69	
T70	Observation 104 118	MAL PRONÓSTICO
#56	AnnotatorNotes T70	C0278252; Prognosis bad; Finding
T71	Observation 355 369	MAL PRONÓSTICO
#57	AnnotatorNotes T71	C0278252; Prognosis bad; Finding
R3	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T70	
R4	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T71	
R5	Experiences Arg1:T44 Arg2:T2	
R6	Experiences Arg1:T44 Arg2:T70	
R7	Experiences Arg1:T44 Arg2:T4	
R8	Experiences Arg1:T44 Arg2:T6	
R9	Experiences Arg1:T44 Arg2:T5	
R10	Combined_with Arg1:T6 Arg2:T7	
R11	Combined_with Arg1:T5 Arg2:T7	
R12	Combined_with Arg1:T14 Arg2:T15	
R13	Combined_with Arg1:T13 Arg2:T15	
#58	AnnotatorNotes T7	C0391001; peginterferon alfa-2a; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#59	AnnotatorNotes T15	C0391001; peginterferon alfa-2a; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
R14	Experiences Arg1:T44 Arg2:T3	
R15	Experiences Arg1:T44 Arg2:T8	
R16	Location_of Arg1:T63 Arg2:T8	
R17	Experiences Arg1:T45 Arg2:T2	
R18	Experiences Arg1:T45 Arg2:T70	
R19	Experiences Arg1:T45 Arg2:T4	
R20	Experiences Arg1:T45 Arg2:T6	
R21	Experiences Arg1:T45 Arg2:T3	
R22	Experiences Arg1:T45 Arg2:T8	
T72	Observation 209 230	MUTACIÓN D816V DE KIT
#60	AnnotatorNotes T72	C3506399; kit gene d816v variant; Finding
T73	GENE 227 230	KIT
#61	AnnotatorNotes T73	C1416655; KIT gene; Gene or Genome
T74	GENE 478 481	KIT
#62	AnnotatorNotes T74	C1416655; KIT gene; Gene or Genome
R23	Experiences Arg1:T45 Arg2:T72	
R24	Experiences Arg1:T44 Arg2:T72	
R25	Location_of Arg1:T73 Arg2:T3	
T75	Observation 460 481	MUTACIÓN D816V DE KIT
#63	AnnotatorNotes T75	C3506399; kit gene d816v variant; Finding
R26	Location_of Arg1:T74 Arg2:T11	
R27	Location_of Arg1:T64 Arg2:T16	
R28	Experiences Arg1:T46 Arg2:T10	
R29	Experiences Arg1:T46 Arg2:T71	
R30	Experiences Arg1:T46 Arg2:T12	
R31	Experiences Arg1:T46 Arg2:T14	
R32	Experiences Arg1:T46 Arg2:T13	
R33	Experiences Arg1:T46 Arg2:T11	
R34	Experiences Arg1:T46 Arg2:T75	
R35	Experiences Arg1:T46 Arg2:T16	
R36	Experiences Arg1:T47 Arg2:T10	
R37	Experiences Arg1:T47 Arg2:T71	
R38	Experiences Arg1:T47 Arg2:T12	
R39	Experiences Arg1:T47 Arg2:T14	
R40	Experiences Arg1:T47 Arg2:T13	
R41	Experiences Arg1:T47 Arg2:T11	
R42	Experiences Arg1:T47 Arg2:T75	
R43	Experiences Arg1:T47 Arg2:T16	
T76	Observation 596 610	mutación D816V
#64	AnnotatorNotes T76	C3506399; kit gene d816v variant; Finding
T77	Observation 821 835	mutación D816V
#65	AnnotatorNotes T77	C3506399; kit gene d816v variant; Finding
R44	Location_of Arg1:T65 Arg2:T19	
R45	Location_of Arg1:T66 Arg2:T30	
R46	Overlap Arg1:T10 Arg2:T11	
R47	Overlap Arg1:T10 Arg2:T75	
R48	Overlap Arg1:T10 Arg2:T16	
R49	Overlap Arg1:T17 Arg2:T18	
R50	Overlap Arg1:T17 Arg2:T76	
R51	Overlap Arg1:T17 Arg2:T19	
R52	Overlap Arg1:T21 Arg2:T38	
R53	Overlap Arg1:T21 Arg2:T22	
R54	Overlap Arg1:T21 Arg2:T77	
R55	Overlap Arg1:T21 Arg2:T30	
T78	Observation 802 812	progresión
#66	AnnotatorNotes T78	C1457868; Worse; Finding (?)
R56	Before Arg1:T38 Arg2:T78	
R57	Overlap Arg1:T21 Arg2:T78	
R58	Location_of Arg1:T24 Arg2:T49	
R59	Location_of Arg1:T24 Arg2:T23	
#67	AnnotatorNotes T23	C0086565; Liver Dysfunction; Finding
T79	Result_or_Value 1002 1013	≥ 2.0 mg/dl
R63	Has_Result_or_Value Arg1:T25 Arg2:T79	
T80	Result_or_Value 1025 1069	>3 veces el límite superior de la normalidad
R64	Has_Result_or_Value Arg1:T40 Arg2:T80	
R65	Has_Result_or_Value Arg1:T27 Arg2:T80	
R67	Negation Arg1:T67 Arg2:T60	
#68	AnnotatorNotes T60	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
R68	Overlap Arg1:T23 Arg2:T28	
#69	AnnotatorNotes T54	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
R69	Negation Arg1:T52 Arg2:T54	
R70	Overlap Arg1:T29 Arg2:T31	
T81	Result_or_Value 1150 1161	≥ 2.0 mg/dL
R71	Has_Result_or_Value Arg1:T42 Arg2:T81	
R72	Location_of Arg1:T41 Arg2:T50	
R73	Location_of Arg1:T41 Arg2:T29	
#70	AnnotatorNotes T29	C0151746; Abnormal renal function; Pathologic Function
T82	Quantifier_or_Qualifier 1210 1222	grado III-IV
R76	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T82	
R77	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T53	
R78	Negation Arg1:T51 Arg2:T53	
R79	Overlap Arg1:T32 Arg2:T33	
#71	AnnotatorNotes T53	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
T83	Result_or_Value 1280 1292	grado III/IV
R80	Has_Result_or_Value Arg1:T55 Arg2:T83	
R81	Location_of Arg1:T36 Arg2:T62	
R82	Location_of Arg1:T36 Arg2:T35	
T84	Result_or_Value 1352 1357	< 50%
R84	Has_Result_or_Value Arg1:T35 Arg2:T84	
T85	Quantifier_or_Qualifier 1272 1278	severa
#72	AnnotatorNotes T85	C1547227; Severe - Severity of Illness Code; Intellectual Product
R88	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T85	
R89	Has_Age Arg1:T58 Arg2:T59	
R90	Negation Arg1:T61 Arg2:T37	
T86	Quantifier_or_Qualifier 1441 1448	fiables
A6	Assertion T86 Negated
#73	AnnotatorNotes T86	C3858758; Reliable; Functional Concept
R91	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T86	
R92	Negation Arg1:T61 Arg2:T86	
R93	Experiences Arg1:T58 Arg2:T37	
T87	Result_or_Value 882 885	≤ 3
T88	CONC 877 881	ECOG
#74	AnnotatorNotes T88	C1520224; ECOG performance status; Intellectual Product
R94	Has_Result_or_Value Arg1:T88 Arg2:T87	
R95	Overlap Arg1:T2 Arg2:T72	
R96	Overlap Arg1:T2 Arg2:T8	
R97	Overlap Arg1:T2 Arg2:T3	
A7	Experiencer T44 Patient
A8	Experiencer T45 Patient
A9	Experiencer T46 Patient
A10	Experiencer T47 Patient
A11	Experiencer T58 Patient
